HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Kim, D.-J. Articles by Barrett-Connor, E. Search for Related Content PubMed PubMed Citation Articles by Kim, D.-J. Articles by Barrett-Connor, E. Social Bookmarking                What's this?

Association of Serum Proinsulin With Hormone Replacement Therapy in Nondiabetic Older Women

The Rancho Bernardo Study

¹ Department of Family and Preventive Medicine, School of Medicine, University of California, San Diego, La Jolla, California
² Department of Internal Medicine, Ilsanpaik Hospital, College of Medicine, Inje University, Koyang, Kyeonggido, South Korea

Address correspondence reprint requests to Elizabeth Barrett-Connor, MD, Department of FamilyPreventive Medicine, School of Medicine, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093-0607. E-mail: ebarrettconnor{at}ucsd.edu

OBJECTIVE—One putative benefit of hormone replacement therapy (HRT) is a reduced risk of diabetes or reduced fasting glucose level. We report here the association of HRT with proinsulin, insulin, and fasting and postchallenge glucose levels in older adults.

RESEARCH DESIGN AND METHODS—Current HRT use was validated and cross-sectionally compared with diabetes-related variables in 785 women without diabetes by history or glucose tolerance test.

RESULTS—Median age was 72 years (range 50–97); median value of fasting plasma glucose, postchallenge plasma glucose, and proinsulin was 5.08 mmol/l, 6.93 mmol/l, and 9.3 pmol/l, respectively. In age-adjusted comparisons, current HRT use was associated with significantly lower fasting plasma glucose and higher postchallenge plasma glucose compared with never/previous HRT use, as well as with lower LDL and higher HDL cholesterol and higher triglycerides. Fasting and postchallenge intact insulin did not differ by HRT group, but proinsulin was significantly lower in current HRT users than in previous and never HRT users. The significant association between proinsulin and HRT status persisted after adjustment for age, waist-to-hip ratio, pulse pressure, LDL-to-HDL cholesterol ratio, triglycerides, fasting and postchallenge glucose, and intact insulin.

CONCLUSIONS—Reduced fasting and increased 2-h glucose replicate findings in a randomized clinical trial. The proinsulin effect has not been previously reported. Decreased fasting glucose and proinsulin levels in current HRT use suggest a potential antidiabetes effect of HRT. Increased postchallenge glucose in HRT, however, suggests insulin resistance and would be expected to increase the risk of heart disease.

Abbreviations: CHD, coronary heart disease • DEXA, dual-energy X-ray absorptiometry • HERS, Heart and Estrogen/Progestin Replacement Study • HOMA-R, R value of homeostasis model assessment • HRT, hormone replacement therapy • PAI-1, plasminogen activator-1 • PEPI, Postmenopausal Estrogen/Progestin Interventions • WHI, Women’s Health Initiative

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?